BARTON HOUSE GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: F84008 | LONDON, N16 9JT
Showing results 101-150 of 593
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Doxycycline hyclate | 389 | 6,167 | £586 | -24.1% ▼ |
| Montelukast | 386 | 12.9K | £1.3K | -43.6% ▼ |
| Procyclidine hydrochloride | 377 | 10.2K | £477 | +166.5% ▲ |
| Buprenorphine | 375 | 3,710 | £5.8K | +2.4% ▲ |
| Dihydrocodeine tartrate | 369 | 27.7K | £1.8K | +88.9% ▲ |
| Atenolol | 367 | 18.9K | £427 | -39.1% ▼ |
| Methadone hydrochloride | 367 | 107.5K | £1.1K | -61.1% ▼ |
| Loratadine | 366 | 14.7K | £342 | +75.2% ▲ |
| Perindopril erbumine | 363 | 14.3K | £1.0K | -31.6% ▼ |
| Clarithromycin | 357 | 9,319 | £1.8K | +45.5% ▲ |
| Donepezil hydrochloride | 356 | 6,216 | £260 | +15.4% ▲ |
| Hydroxocobalamin | 352 | 445 | £964 | -26.9% ▼ |
| Mesalazine (Systemic) | 349 | 38.7K | £21.0K | +45.7% ▲ |
| Hypromellose | 345 | 6,110 | £1.8K | +160.4% ▲ |
| 345 | 384 | £2.0K | +46.1% ▲ | |
| Digoxin | 344 | 7,210 | £555 | -9.1% ▼ |
| Sumatriptan succinate | 343 | 3,232 | £1.5K | -3.1% ▼ |
| Enalapril maleate | 341 | 17.8K | £693 | +89.8% ▲ |
| Warfarin sodium | 339 | 19.4K | £697 | -28.1% ▼ |
| Quinine sulfate | 339 | 8,897 | £1.3K | +17.1% ▲ |
| Beclometasone dipropionate | 328 | 395 | £1.1K | +52.5% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 327 | 28.9K | £1.1K | +6.7% ▲ |
| Lactulose | 326 | 178.1K | £1.7K | -1.0% vs avg |
| Nifedipine | 315 | 9,547 | £1.5K | +68.1% ▲ |
| Mirabegron | 315 | 11.0K | £10.1K | -21.6% ▼ |
| Methylphenidate hydrochloride | 310 | 18.3K | £11.5K | +20.0% ▲ |
| Cyanocobalamin | 310 | 14.2K | £1.7K | -12.2% ▼ |
| Repaglinide | 305 | 34.1K | £2.5K | +1,161.3% ▲ |
| Latanoprost | 299 | 9,143 | £2.8K | -38.4% ▼ |
| 299 | 34.0K | £1.6K | +8.1% ▲ | |
| Lercanidipine hydrochloride | 295 | 7,581 | £714 | -52.2% ▼ |
| Sacubitril/valsartan | 287 | 14.5K | £23.8K | +19.8% ▲ |
| Insulin glargine | 286 | 2,025 | £14.2K | +0.7% vs avg |
| Glyceryl trinitrate | 284 | 634 | £825 | +20.1% ▲ |
| Mebeverine hydrochloride | 280 | 16.7K | £745 | -9.8% ▼ |
| Moxonidine | 278 | 8,372 | £1.1K | +399.4% ▲ |
| Pantoprazole | 276 | 12.0K | £572 | +0.4% vs avg |
| Fluticasone propionate (Nasal) | 276 | 2,796 | £4.0K | +89.6% ▲ |
| Solifenacin | 275 | 11.4K | £687 | -42.4% ▼ |
| Levetiracetam | 268 | 25.9K | £3.5K | -41.5% ▼ |
| Sodium valproate | 266 | 21.5K | £4.1K | -16.4% ▼ |
| Irbesartan | 262 | 7,532 | £326 | +7.5% ▲ |
| Rivaroxaban | 254 | 10.2K | £7.3K | -58.5% ▼ |
| Prochlorperazine maleate | 254 | 10.9K | £620 | +25.7% ▲ |
| Memantine hydrochloride | 253 | 8,732 | £3.0K | -23.4% ▼ |
| Ketoconazole | 253 | 39.4K | £5.5K | +157.7% ▲ |
| Fluticasone propionate (Inhalation) | 252 | 457 | £10.8K | -34.9% ▼ |
| Isophane insulin | 251 | 1,697 | £7.4K | +137.7% ▲ |
| Felodipine | 250 | 10.2K | £1.6K | -57.9% ▼ |
| Lithium carbonate | 249 | 8,484 | £1.3K | +96.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.